Variant report
Variant | nsv9582 |
---|---|
Chromosome Location | chr17:60297270-60313567 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:60186542..60187081-chr17:60304052..60304558,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538148519 | chr17:60297311-60297312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs554920887 | chr17:60297329-60297330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs188338179 | chr17:60297353-60297354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs11657264 | chr17:60297393-60297394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs140612293 | chr17:60310170-60310171 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs538625888 | chr17:60310189-60310190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs530239959 | chr17:60310231-60310232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs4059229 | chr17:60310241-60310242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs12451187 | chr17:60310261-60310262 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs575633319 | chr17:60310288-60310289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs11658038 | chr17:60310335-60310336 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs141273998 | chr17:60310351-60310352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs573841062 | chr17:60310412-60310413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs190384501 | chr17:60310424-60310425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs559660318 | chr17:60310433-60310434 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs528417183 | chr17:60310443-60310444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544664357 | chr17:60310469-60310470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs547929076 | chr17:60310496-60310497 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs537925467 | chr17:60310504-60310505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs564937691 | chr17:60310580-60310581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs181593039 | chr17:60310589-60310590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs550211166 | chr17:60310608-60310609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs71375824 | chr17:60310610-60310611 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs530195412 | chr17:60310612-60310613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs62070759 | chr17:60310618-60310619 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs138109206 | chr17:60310628-60310629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs539353125 | chr17:60310668-60310669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs558125942 | chr17:60310670-60310671 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs558670618 | chr17:60310681-60310682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs149456895 | chr17:60310696-60310697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs537861310 | chr17:60310722-60310723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs555067086 | chr17:60310743-60310744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs11658307 | chr17:60310792-60310793 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs190904718 | chr17:60310839-60310840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs184239130 | chr17:60310866-60310867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs553240636 | chr17:60310869-60310870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs534571486 | chr17:60310898-60310899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs140361170 | chr17:60310900-60310901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs187574085 | chr17:60310915-60310916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs61193383 | chr17:60310921-60310922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs191175656 | chr17:60310924-60310925 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs9889923 | chr17:60310949-60310950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs148553955 | chr17:60310954-60310955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs4089480 | chr17:60310958-60310959 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs202104669 | chr17:60310964-60310965 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs182904159 | chr17:60310980-60310981 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs560777614 | chr17:60311003-60311004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs532691405 | chr17:60311112-60311113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs552796122 | chr17:60311146-60311147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs4095506 | chr17:60311153-60311154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Melanoma | 18172304 | CNVD |
Moyamoya disease | 22323933 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chordoma | 21602918 | CNVD |
Neurofibromatosis | 20686819 | CNVD |
Peripheral nerve sheath tumors | 20686819 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Breast cancer | 21264507 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Gastric cancer | 17167181 | CNVD |
Breast cancer | 19287154 | CNVD |
Leukemia | 20874852 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Bladder cancer | 21909424 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21364760 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 21509527 | CNVD |
Chordoma | 18071362 | CNVD |
Cancer | 16751803 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 21523713 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 16397240 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 21858162 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
XY sex reversal | 17503084 | CNVD |
Sensorineural hearing loss | 22052739 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17899364 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Breast cancer | 16620391 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21611746 | CNVD |
Williams-Beuren syndrome | 16971481 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21958427 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Congenital Hypertrichosis Syndrome | 21636067 | CNVD |
Cancer | 21129771 | CNVD |
Non-syndromic sensorineural hearing loss | 17431168 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:60297000-60297400 | Enhancers | Primary monocytes fromperipheralblood | blood |
2 | chr17:60310000-60312000 | Enhancers | K562 | blood |
3 | chr17:60312000-60315600 | Weak transcription | K562 | blood |